News | June 04, 2024
Aurigene Pharmaceutical opens biologics facility in Genome Valley, Hyderabad
The state-of-the-art facility is equipped with best-in-class equipment and control systems
The state-of-the-art facility is equipped with best-in-class equipment and control systems
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Executes the first project for developing and manufacturing a novel anticancer mAb
If approved, enfortumab vedotin with KEYTRUDA would be the first combination in China to offer an alternative to chemotherapy
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Both organisations enter into a long- term collaboration to expand patient access in India
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Subscribe To Our Newsletter & Stay Updated
